In HFD-induced obese mice these peptides improved obesity and insulin resistance [156], pointing out that the obesogenic and insulin-resistant effect of EPO is intimately related to its hematopoietic effect. The gene discussed is EPO; the disease is obesity due to melanocortin 4 receptor deficiency.